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Abstract
The death process of Candida albicans was investigated after treatment with the antifungal agents flucytosine and
amphotericin B by assessing morphological and biophysical properties associated with cell death. C. albicans was treated
varying time periods (from 6 to 48 hours) and examined by scanning electron microscopy (SEM) and atomic force
microscopy (AFM). SEM and AFM images clearly showed changes in morphology and biophysical properties. After drug
treatment, the membrane of C. albicans was perforated, deformed, and shrunken. Compared to the control, C. albicans
treated with flucytosine was softer and initially showed a greater adhesive force. Conversely, C. albicans treated with
amphotericin B was harder and had a lower adhesive force. In both cases, the surface roughness increased as the treatment
time increased. The relationships between morphological changes and the drugs were observed by AFM clearly; the surface
of C. albicans treated with flucytosine underwent membrane collapse, expansion of holes, and shrinkage, while the
membranes of cells treated with amphotericin B peeled off. According to these observations, the death process of C.
albicans was divided into 4 phases, CDP0, CDP1, CDP2, and CDP4, which were determined based on morphological changes.
Our results could be employed to further investigate the antifungal activity of compounds derived from natural sources.
Citation: Kim KS, Kim Y-S, Han I, Kim M-H, Jung MH, et al. (2011) Quantitative and Qualitative Analyses of the Cell Death Process in Candida albicans Treated by
Antifungal Agents. PLoS ONE 6(12): e28176. doi:10.1371/journal.pone.0028176
Editor: Andre Van Wijnen, University of Massachusetts Medical, United States of America
Received September 27, 2011; Accepted November 2, 2011; Published December 9, 2011
Copyright:  2011 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program
(Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: webhospital@naver.com (MHJ); sigmoidus@khu.ac.kr (H-KP)
. These authors contributed equally to this work.
" These authors also contributed equally to this work.
Introduction
Candida albicans (C. albicans) is a dimorphic organism that forms
either a yeast or a mycelium depending on the growth
environment. C. albicans is normally present on the skin and in
mucous membranes such as the vagina, mouth, and rectum in
80% of the human population with no harmful effects; overgrowth
results in candidiasis, which is generally easily cured [1–5].
However, candidiasis can sometimes result in serious opportunistic
infections when the immune system is compromised, and is an
important cause of morbidity and mortality in immunocompro-
mised patients with diseases such the human immunodeficiency
virus (HIV), or undergoing chemotherapy, organ or bone marrow
transplantation. Mortality associated with candidiasis can be as
high as 30–50% in patients undergoing transplantation and 40%
of those with HIV [5].
The current antifungal agents available to treat candidiasis can be
divided into two groups depending on mechanism of action [6]. One
group acts mainly on cell walls or membranes, while the other attacks
intracellular pathways. The antifungal agents of the former group are
typically azole-type drugs, which are ergosterol inhibitors or
b-glucagon synthase inhibitors [6]. Those in the latter group include
pyrimidine analogues, thymidylate synthase inhibitors, and mitotic
inhibitors [6]. However, treatment of C. albicans infections with these
drugs may lead to side effects such as hepatotoxicity and
nephrotoxicity [7], resistance, and frequent recurrence. For these
reasons, treatment using home remedies has been widely introduced
worldwide, and new antifungal agents from natural resources are
being studied intensively. Several natural compounds show antifungal
activity, including Euphorbia hirta L[ 3 ] ,Eqoul, which is found in
soybean [4], Tribulus terrestris L[ 8 ] ,a n dAllicin,w h i c hi sf o u n di ng a r l i c
[7]. Despite several reports describing drugs extracted from natural
resources, thus far, very little is known about their antifungal activities.
In this work, we demonstrate the death process of C. albicans
after the use of two commonly used antifungal agents, flucytosine
and amphotericin B. Both have been used in the treatment of
candidiasis, and their mechanisms of actions are well known. We
investigated changes in morphology and biophysical properties of
C. albicans treated with flucytosine and amphotericin B using
scanning electron microscopy (SEM) and atomic force microscopy
(AFM). The findings of this work may be used in future studies to
investigate the antifungal activities of natural drugs.
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The antifungal activities of flucytosine and amphotericin B were
estimated using a cell viability assay. The rates of C. albicans
viability as a function of drug treatment time from 0 (control) to
48 hours are shown in Figure 1. The inset shows results for
treatment times from h=6toh=48. When C. albicans was exposed
to either antifungal drugs for h=6, the viability decreased by 90%.
When the cells were exposed for longer periods (h.12), the
viability increased according to treatment time. This result was not
unexpected, as it represented not a waning of the effects of the
antifungal drugs but the budding of new cells that were unaffected
by the drug. The increase in viability was greater in flucytosine
treated cells than in amphotericin B treated cells, indicating that C.
albicans is more sensitive to amphotericin B.
SEM images of C. albicans cells untreated (A), treated with
flucytosine (B) or treated with amphotericin B (C) revealed
ultrastructural changes in the C. albicans due to the antifungal
drugs (Fig. 2). Untreated cells had well defined, intact shapes with
smooth surfaces. Cells treated with drugs showed considerable
morphological alterations including deformation and shrinkage. In
both cases, the cells were significantly destroyed when treated
more than 12 hours.
Representative AFM images of the C. albicans treated with
flucytosine (A) and amphotericin B (B) are shown in Figure 3. The
AFM images clearly show nanoscale morphological changes
induced by the antifungal drugs. The most dramatic changes in
the membrane of C. albicans after treatment with antifungal drugs
were observed when the cells were exposed to the drugs for
6 hours. Cells treated with flucytosine were just starting to show
collapse of the outer membrane and their shape was becoming
irregular compared to the untreated cells (Fig. 3A). In the case of
Figure 1. Cell viability of C. albicans as a function of antifungal drug treatment time. The cells were treated with two commonly used
antifungal drugs, flucytosine and amphotericin B.
doi:10.1371/journal.pone.0028176.g001
Figure 2. SEM images of C. albicans cells. A is the image of
untreated cell. B and C show images cells treated with flucytosine (A)
and amphotericin B (B) for h=6, 12, and 18, respectively.
doi:10.1371/journal.pone.0028176.g002
Analyses Cell Death Process in Candida albicans
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28176cells treated with amphotericin B (Fig. 3B), the outer membranes
were peeling off instead of collapsing. For treatments longer than
12 hours, both cell treatments showed similar changes in the shape
and morphology including deformation and shrinkage. These
changes are similar to the results observed with SEM.
AFM provides a three-dimensional image of the cell surface on
a nanometer scale. In the treated cells, the three dimensional
structures of C. albicans differed in Z axis values according to the
drug treatment time. In cells treated with flucytosine, the Z axis
values were 240 nm/div, 150 nm/div and 80 nm/div at h=6, 12,
and 18, respectively (Fig. 4B). In cells treated with amphotericin B,
the values were 300 nm/div, 200 nm/div, and 100 nm/div at
h=6, 12, and 18, respectively (Fig. 4B).
According to SEM and AFM images, the cell death phase
(CDP) of C. albicans can be divided into four steps (Fig. 5). The first
step is CDP0, in which the cells are not visibly affected by the drug
and show very clear, intact, and defined shapes. The second step is
CDP1, in which the cell shape is partially deformed, collapsed or
peeled off depending on the type of antifungal drug used. The
third step is CDP2, in which the cells lose their original shapes and
porosity is expanded. The width and depth of the hole is about 50–
70% of the cell diameter. The final step is CDP3, in which the cells
are shrunken and completely destroyed.
The effects of antifungal drugs on the biophysical properties of
C. albicans were also investigated using AFM measurements.
Obvious changes in stiffness, adhesive force, and roughness were
observed in both groups of treated cells (Fig. 6), but the changes
seen were dependent on the type of antifungal drug used.
Compared to untreated cells, the cells treated with flucytosine
were softer, while the cells treated with amphotericin B were
harder (Fig. 6a). The stiffness did not change with the use of CDP
in either case. The adhesive force of cells treated with flucytosine
was lower than that of untreated cells (Fig. 6b). The adhesive force
of cells treated with amphotericin B was greater than that of the
untreated cell at CDP1, but decreased to a similar or lower value
than CDP0 at CDP2 and CDP3. Since the membrane shrinks as
the cell is destroyed, the roughness of the cell surface was increased
in both groups of treated cells (Fig. 6c).
Discussion
Although C. albicans is most often associated with candidiasis,
the development of a universal therapeutic approach to C. albicans
infection is still a great challenge because of the vast problems
faced with conventional treatments such as toxicity, side effects,
resistance, and relapse [3]. The use of natural products and home
remedies for the treatment of candidiasis has been gaining
popularity both in practical use and in research. Studies of natural
drugs showing in vitro antifungal activities were first performed by
Maruzzella and others in 1958 [9]. Since then, a variety of natural
antifungal compounds have been discovered [3,4,7,8], but the
mechanisms of action of these natural compounds are not yet fully
understood. To understand the antifungal activity of drugs from
natural sources, it is necessary to clearly show the death process of
C. albicans in both quantitative and qualitative terms. Thus, in this
work, the CDP of C. albicans induced by two commonly used
antifungal drugs of flucytosine and amphotericin B was investi-
gated using SEM and AFM by measuring cell viability, and
morphological and biophysical properties.
Antifungal agents affect the morphology and physical properties
of cells, such as shape, size, height, roughness and stiffness [10–
13]. Adherence of cells is also affected by antifungal agents.
Several works suggested that the activity of antifungal agents can
be evaluated by changes in morphology and physical properties of
the fungal cells. Using transmission electron microscopy (TEM),
SEM, and AFM, morphological changes in C. albicans have been
investigated qualitatively. TEM is a microscopy technique to use a
beam of electrons, which is transmitted through a thin sample and
interacted with the sample as it passes through. Therefore, it is
usually employed to see inner part of the sample. The SEM images
a sample by scanning it with a high-energy beam of electrons, and
it is capable of imaging at a significantly higher resolution than
light microscopes. However, for SEM imaging, a biological sample
should be completely dry, because the sample chamber is at high
vacuum. Tyagi et al. investigated the antimicrobial activity of
lemon grass oil against C. albicans observed by in situ TEM, SEM,
and AFM [10] and determined that C. albicans treated with LGO
vapor ruptured completely, cells treated with LGO in broth
shrank and that the surface roughness of cells treated with LGO
was significantly higher in control C. albicans than in treated cells.
In recent years, it has been increased the preference of AFM in
biomaterial imaging since its several advantages over the other
spectroscopy. AFM provides not only a two-dimensional image of
a sample but also a three-dimensional surface profile. For AFM
imaging, the samples do not require any special treatments such as
coatings with metal or carbon, and dry. Additionally, the images
can be obtained in ambient air or even a liquid environment. Adya
et al. investigated the toxic effects of ethanol on yeast cell surface
morphology using AFM [11]. The cell surface morphological
changes were correlated with cellular stress physiology. By
exposing yeast to increasingly stressful concentrations of ethanol,
cell viabilities and mean cell volumes were decreased.
In this work, the morphological changes of C. albicans induced
by antifungal drugs were clearly revealed by SEM and AFM.
Especially, the dependence of morphological changes on the
mechanism of action of antifungal agents was clearly distinguished
in the AFM images. As shown in Fig. 3(A), the death process of C.
albicans treated by flucytosine was accompanied by membrane
collapse, expansion of the hole, and shrinkage. These changes can
Figure 3. AFM images of C. albicans cells. A and B show images of
cells treated with flucytosine and amphotericin B for h=6, 12, and 18,
respectively.
doi:10.1371/journal.pone.0028176.g003
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flucytosine is a fluorinated pyrimidine analog which mainly acts on
RNA and DNA. It shows antifungal activity by inhibiting RNA
and fungal replication by DNA synthesis inhibition [14] and is
metabolized into 5-fluorouracil. The damaged RNA and DNA
prevent a normal metabolism, a protein synthesis, and are
accompanied by the destruction of microtubule. According to this
mechanism, it thought to be that the interior of the cell is firstly
destroyed by the flucytosine and it eventually results the collapses
the outer membrane. While the C. albicans treated with
amphotericin B shows a quite different cell death process as
shown in Fig. 3(B). The membranes of cells treated with
Figure 4. Three-dimensional AFM images. A and B correspond to three-dimensional images of Fig. 3(A) and (B), respectively.
doi:10.1371/journal.pone.0028176.g004
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observed mainly after 6 hours treatment. By the further treatment,
the membrane was holed and shrunk as like the cell treated by
flucytosine. These morphological changes also show a good
agreement with the mechanism of action of amphotericin B.
The Amphotericin B which is antifungal polyene is known to acts
on cell walls and membranes even though the precise mechanism
still remains unclear [15]. This drug binds to ergosterol, which is
the principal sterol in membrane of fungal cell, and then destroys
the integrity of the fungal membrane. Fortunately, the very subtle
changes in the membrane were detected by AFM.
Physical properties of the cells, such as roughness, stiffness, and
adhesive force, were also obtained by using AFM, and the changes
induced by antifungal drugs were determined quantitatively. Cells
treated with flucytosine were softer than untreated cells, while cells
treated with amphotericin B were harder than untreated cells.
Although it is not yet fully understood how cell stiffness is regulated,
it is known that the stiffness of cell is largely determined by physical
propertyofmembrane,cytoskeletal architecture,andthenetwork of
intermediate filaments. Because of this fact, the cell stiffness can
provide insight into the status and function of the cells. Several
studies reported that the cell stiffness changed with the progression
of diseases [16,17]. The change in the cell stiffness observed in this
work is related to the cell death caused by antifungal agent. The
lowered stiffness in the cell treated with flucytosine can be
understood by the mechanism of action of flucytosine. As
mentioned before, the flucytosine mainly acts on RNA and DNA
synthesis and results in the metabolic disorder. Therefore, the
destroyed cytoskeletal architecture or microtubule is responsible for
the softness of the membrane. The change in the stiffness was not
significantly dependent on the progression of cell death. The larger
stiffness in cells treated with amphotericin B is not well understood,
however,itclearlyshowsthatthechangesinphysicalpropertyofthe
cell depend on variety of antifungal agents.
In both cells, it was not observed a significant change in the
adhesive force except the cell treated with amphotericin B at
CDP1. The adhesive force is the strength of the interaction
between the cell membrane and AFM tip. The force depends on
the sample conditions and dimensions of the tip, which changes
with humidity, temperature, and tip diameter [18]. To minimize
these problems in this work, all images were measured with the tip
manufactured in the same process and the similar environmental
conditions. The adhesive force is also very sensitivity to the
properties of the sample, such as hydrophobic or hydrophilic
Figure 5. Cell death phase (CDP) of C. albicans induced by flucytosine and amphotericin B. The cell death process can be divided by four
phase according to the changes in shape and morphological properties.
doi:10.1371/journal.pone.0028176.g005
Figure 6. Changes in biophysical properties of C. albicans
according to CDP. (A) shows changes in the stiffness of cells treated
by flucytosine and amphotericin B. (B) and (C) show changes in the
adhesive forces and the surface roughness.
doi:10.1371/journal.pone.0028176.g006
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made by silicon which is hydrophobic naturally, but the silicon is
easily oxidized in air and turns to hydrophilic [19]. The mem-
brane is hydrophobic naturally, and its property does not changed
during the cell death process. Therefore, the larger adhesive force
at CDP1 in the cell treated with amphotericin B may be due to
internal secretion occurring after destruction of the cell mem-
brane. Strictly speaking, it is not an adhesive force of the cell, but a
force caused by certain sticky substance secreted in the cell.
In conclusion, the effects of two antifungal drugs on C. albicans
were investigated by SEM and AFM. It was observed the mor-
phological changes according to the treatment conditions, and the
changes in the biophysical properties were determined quantita-
tively. The cell death process was defined based on the changes of
morphology and biophysical properties. These findings will be
applied to further analysis of antifungal activity of compounds
derived from natural sources.
Materials and Methods
Culture and preparation of C. albicans
C. albicans was purchased from the American Type Culture
Collection (ATCC, Rockville, MD, USA), maintained in Sabour-
aud broth, and incubated at 37uC for 24 hours in a shaking
incubator at 180 rpm. The samples were centrifuged at 2500 rpm
for 15 minutes and washed in calcium-, magnesium-free phos-
phate-buffered saline (DPBS), and cells were used immediately.
Viability of C. albicans after antifungal treatment
For measurements of antifungal cytotoxicity, C. albicans was
inoculated at 1610
6 cells/ml in Sabouraud broth. C. albicans in cell
suspension were treated with the minimum inhibitory concentra-
tions (MIC)90 of antifungal agents, 1 mg/ml amphotericin B and
1 mg/ml flucytosine. After variable incubation times in a shaking
incubator at 180 rpm, C. albicans cells were centrifuged at
2500 rpm for 15 minutes and then washed with 0.1 M PBS. For
the assessment of cell cytotoxicity, cells were counted using a
hemocytometer after stained with trypan blue dye (1:1) to exclude
non-viable cells. The MIC90 of each drug was determined
according to Graziella et al. [20].
Scanning electron microscopy (SEM)
For SEM measurements, Candida cells were smeared on a
conducting layer as a thin film, and the samples were platinum-
coated by sputtering. SEM observations were made using a FEI
Company W-filament SEM embedded in a Focus Ion Beam.
All observations were conducted under the conditions of
EHT=10.00 kV, Current=0.12 nA, WD=15 mm.
Atomic force microscopy (AFM)
The AFM system used in this study was the NANOStation II
(Surface Imaging Systems, Herzogenrath, Germany), which
consists of an AFM scanner and Zeiss optical microscope (Epiplan
5006). The images of C. albicans were measured in contact mode
(Budget Sensor, Bulgaria) with a reflex-coated silicon cantilever.
The properties of the probe used in imaging were: resonance
frequency of 190 kHz (614 kHz) and force constant of 48 N/m
(61.4 N/m). The images were taken with a resolution of 2566256
pixels and a scan speed of 0.2 line/s.
To perform force-distance (FD) curve measurements, the
sample surface was first scanned to determine an appropriate site
for the force curve without defects or impurities. Cell elasticity was
quantified by the following equations: 1/kcell=1/keffective21/
kcantilever, where keffective and kcantilever was determined from the
slope of the linear region of the FD curve for a cell and a clean
slide glass, respectively [21].
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